Effect of cocoa in diabetes: The potential of the pancreas and liver as key target organs, more than an antioxidant effect?

International Journal of Food Science and Technology

Volumn 51, Issue 4, 2016, Pages 829-841

  Mellor, Duane D ^a,b   Naumovski, Nenad ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antioxidants; Chocolate; Cocoa; Health foods

Indexed keywords

ANTIOXIDANTS; DISEASES; INSULIN;

ANTIOXIDANT EFFECT; CHOCOLATE; HEALTH FOODS; INSULIN SECRETION; INSULIN SENSITIVITY; PANCREATIC BETA CELLS; PANCREATIC FUNCTIONS; TYPE 2 DIABETES MELLITUS;

COCOA;

EID: 84976241879     PISSN: 09505423     EISSN: 13652621     Source Type: Journal    
DOI: 10.1111/ijfs.13075     Document Type: Review

References (92)

1. Adams, L.A., Waters, O.R., Knuiman, M.W., Elliott, R.R. & Olynyk, J.K. (2009). NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. American Journal of Gastroenterology, 104, 861-867.
2. Almoosawi, S., Fyfe, L., Ho, C. & Al-Dujaili, E. (2010). The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. British Journal of Nutrition, 103, 842-850.
3. Almoosawi, S., Tsang, C., Ostertag, L.M., Fyfe, L. & Al-Dujaili, E.A.S. (2012). Differential effect of polyphenol-rich dark chocolate on glucoregulatory and cardiovascular risk factors on healthy overweight and obese subjects: a randomized clinical trial. Food and Function, 3, 1035-1043.
4. Basaranoglu, M., Basaranoglu, G. & Bugianesi, E. (2015). Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surgery and Nutrition, 4, 109-116.
5. Beagley, J., Guariguata, L., Weil, C. & Motala, A.A. (2014). Global estimates of undiagnosed diabetes in adults. Diabetes Research and Clinical Practice, 103, 150-160.
6. Berends, L.M., van der Velpen, V. & Cassidy, A. (2015). Flavan-3-ols, theobromine, and the effects of cocoa and chocolate on cardiometabolic risk factors. Current Opinion in Lipidology, 26, 10-19.
7. Bonaccio, M.L., Di Castelnuovo, A., Costanzo, S. et al. (2014). Adherence to the mediterranean diet is associated with reduced overall mortality in subjects with diabetes. Prospective results from the Moli-sani study. European Journal of Preventive Cardiology, 21, S55.
8. Brand-Miller, J., Holt, S.H.A., de Jong, V. & Petocz, P. (2007). Human nutrition and metabolism postprandial insulinemia in. Journal of Nutrition, 133, 3149-3152.
9. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414, 813-820.
10. Carpéné, C., Gomez-zorita, S., Deleruyelle, S. & Carpéné, M.A. (2015). Novel strategies for preventing diabetes and obesity complications with natural polyphenols. Current Medicinal Chemistry, 22, 150-164.
11. Carter, P., Gray, L.J., Troughton, J., Khunti, K. & Davies, M.J. (2010). Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. British Medical Journal, 341, c4229.
12. Chalasani, N., Younossi, Z., Lavine, J.E. et al. (2012). The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology, 142, 1592-1609.
13. Cooper, K.A., Donovan, J.L., Waterhouse, A.L. & Williamson, G. (2008). Cocoa and health: a decade of research. British Journal of Nutrition, 99, 1-11.
14. Cordero-Herrera, I., Martín, M.A., Bravo, L., Goya, L. & Ramos, S. (2013). Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells. Molecular Nutrition & Food Research, 57, 974-985.
15. Cordero-Herrera, I., Martín, M.Á., Goya, L. & Ramos, S. (2014). Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. Food and Chemical Toxicology, 64, 10-19.
16. Cordero-Herrera, I., Martín, M.Á., Escrivá, F., Álvarez, C., Goya, L. & Ramos, S. (2015a). Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats. Journal of Nutritional Biochemistry, 26, 704-712.
17. Cordero-Herrera, I., Martín, M.Á., Fernández-Millán, E., Álvarez, C., Goya, L. & Ramos, S. (2015b). Cocoa and cocoa flavanol epicatechin improve hepatic lipid metabolism in in vivo and in vitro models. Role of PKCζ. Journal of Functional Foods, 17, 761-773.
18. Cordero-Herrera, I., Martín, M.A., Goya, L. & Ramos, S. (2015c). Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: relevance of MAPKs. Molecular Nutrition & Food Research, 59, 597-609.
19. Cordero-Herrera, I., Martín, M.Á., Goya, L. & Ramos, S. (2015d). Cocoa intake ameliorates hepatic oxidative stress in young Zucker diabetic fatty rats. Food Research International, 69, 194-201.
20. Curtis, P.J., Sampson, M., Potter, J., Dhatariya, K., Kroon, P.A. & Cassidy, A. (2013a). Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated post menopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial. Diabetes Care, 35, 226-232.
21. Curtis, P.J., Potter, J., Kroon, P.A. et al. (2013b). Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. American Journal of Clinical Nutrition, 97, 936-942.
22. Davison, K., Coates, A.M., Buckley, J.D. & Howe, P.R.C. (2008). Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. International Journal of Obesity, 32, 1289-1296.
23. De Gottardi, A., Berzigotti, A., Seijo, S. et al. (2012). Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial. American Journal of Clinical Nutrition, 96, 584-590.
24. Dorenkott, M.R., Griffin, L.E., Goodrich, K.M. et al. (2014). Oligomeric cocoa procyanidins possess enhanced bioactivity compared to monomeric and polymeric cocoa procyanidins for preventing the development of obesity, insulin resistance, and impaired glucose tolerance during high-fat feeding. Journal of Agriculture and Food Chemistry, 62, 2216-2227.
25. Dower, J.I., Geleijnse, J.M., Gijsbers, L., Zock, P.L. & Kromhout, D. (2015). Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health : a randomized, double-blind. American Journal of Clinical Nutrition, 101, 914-921.
26. Dragan, S., Andrica, F., Serban, M.-C. & Timar, R. (2015). Polyphenols-rich natural products for treatment of diabetes. Current Medicinal Chemistry, 22, 14-22.
27. Dyson, P.A., Kelly, T., Deakin, T. et al. (2011). Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine, 28, 1282-1288.
28. Evert, A.B., Boucher, J.L., Cypress, M. et al. (2013). Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care, 36, 3821-3842.
29. FDA (2012). Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods, Release 2 (2010) [WWW Document]. URL http://www.ars.usda.gov/Services/docs.htm?docid=15866
30. Fernández-Millán, E., Cordero-Herrera, I., Ramos, S. et al. (2015). Cocoa-rich diet attenuates beta cell mass loss and function in young Zucker diabetic fatty rats by preventing oxidative stress and beta cell apoptosis. Molecular Nutrition & Food Research, 59, 820-824.
31. Fu, Z., Yuskavage, J. & Liu, D. (2013). Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice. Journal of Agriculture and Food Chemistry, 61, 4303-4309.
32. Fulton, J.J., Plewig, G. & Kligman, A.M. (1969). Effect of chocolate on acne vulgaris. JAMA, 210, 2071-2074.
33. Gibb, C.M., Davies, P.T.G., Glover, V., Steiner, T.J., Rose, F.C. & Sandler, M. (1991). Chocolate is a migraine-provoking agent. Cephalalgia, 11, 93-95.
34. Grassi, D., Lippi, C., Necozione, S., Desideri, G. & Ferri, C. (2005). Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. American Journal of Clinical Nutrition, 81, 611-614.
35. Grassi, D., Desideri, G., Necozione, S. et al. (2008). Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. Journal of Nutrition, 138, 1671-1676.
36. Gu, Y., Yu, S. & Lambert, J.D. (2014). Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice. European Journal of Nutrition, 53, 149-158.
37. Hooper, L., Kay, C., Abdelhamid, A. et al. (2012). Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. American Journal of Clinical Nutrition, 95, 740-751.
38. IDF (2013). IDF Diabetes Atlas. Brussels, Belgium: IDF.
39. Jalil, A.M.M. & Ismail, A. (2008). Polyphenols in cocoa and cocoa products: is there a link between antioxidant properties and health? Molecules, 13, 2190-2219.
40. Jalil, A.M.M., Ismail, A., Pei, C.P., Hamid, M. & Kamaruddin, S.H.S. (2008). Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. Journal of Agriculture and Food Chemistry, 56, 7877-7884.
41. Jalil, A.M.M., Ismail, A., Pei, P.C., Hamid, M. & Kamaruddin, S.H.S. (2009). Effects of cocoa extract containing polyphenols and methylxanthines on biochemical parameters of obese-diabetic rats. Journal of the Science of Food and Agriculture, 89, 130-137.
42. Kasturiratne, A., Weerasinghe, S., Dassanayake, A.S. et al. (2012). Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. Journal of Gastroenterology and Hepatology, 28, 1-23.
43. Kawano, Y. & Cohen, D.E. (2013). Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. Journal of Gastroenterology, 48, 434-441.
44. Korenblat, K.M., Fabbrini, E., Mohammed, B.S. & Klein, S. (2008). Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology, 134, 1369-1375.
45. Lalloyer, F., Vandewalle, B., Percevault, F. et al. (2006). Peroxisome proliferator-activated receptor α improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes, 55, 1605-1613.
46. Lee, Y., Hirose, H., Ohneda, M., Johnson, J.H., McGarry, J.D. & Unger, R.H. (1994). Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proceedings of the National Academy of Sciences of the United States of America, 91, 10878-10882.
47. Lewis, G.F., Lewis, G.F., Giacca, A. & Giacca, A. (2002). Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Reviews, 23, 201-229.
48. Ley, S.H., Hamdy, O., Mohan, V. & Hu, F.B. (2014). Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet, 383, 1999-2007.
49. Lim, E.L., Hollingsworth, K.G., Aribisala, B.S., Chen, M.J., Mathers, J.C. & Taylor, R. (2011). Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia, 54, 2506-2514.
50. Lotito, S.B. & Frei, B. (2006). Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?. Free Radical Biology and Medicine, 41, 1727-1746.
51. Marchesini, G. & Mazzotti, A. (2015). NAFLD incidence and remission: only a matter of weight gain and weight loss? Journal of Hepatology, 62, 15-17.
52. Martín, M.Á., Ramos, S., Cordero-Herrero, I., Bravo, L. & Goya, L. (2013). Cocoa phenolic extract protects pancreatic beta cells against oxidative stress. Nutrients, 5, 2955-2968.
53. Martín, M.Á., Cordero-Herrera, I., Bravo, L., Ramos, S. & Goya, L. (2014a). Cocoa flavanols show beneficial effects in cultured pancreatic beta cells and liver cells to prevent the onset of type 2 diabetes. Food Research International, 63, 400-408.
54. Martín, M.Á., Fernández-Millán, E., Ramos, S., Bravo, L. & Goya, L. (2014b). Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Molecular Nutrition & Food Research, 58, 447-456.
55. Mastroiacovo, D., Kwik-Uribe, C., Grassi, D. et al. (2015). Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study - a randomized controlled trial. American Journal of Clinical Nutrition, 101, 538-548.
56. Matsuda, M. & DeFronzo, R.A. (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
57. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
58. Mellor, D.D. (2013). The effects of polyphenol rich chocolate on cardiovascuar risk and glycaemic control in type 2 diabetes mellitus. PhD Thesis. University of Hull.
59. Mellor, D.D., Sathyapalan, T., Kilpatrick, E.S., Beckett, S. & Atkin, S.L. (2010). High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabetic Medicine, 27, 1318-1321.
60. Mellor, D.D., Sathyapalan, T., Kilpatrick, E.S. & Atkin, S.L. (2015). Diabetes and chocolate: friend or foe? Journal of Agriculture and Food Chemistry, 63, 9910-9918.
61. Miller, S.J., Batra, A.K., Shearrer, G.E. et al. (2016). Dietary fibre linked to decreased inflammation in overweight minority youth. Pediatric Obesity, 11, 33-39.
62. Mohamed, S. (2014). Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease. Trends in Food Science & Technology, 35, 114-128.
63. Muniyappa, R., Hall, G., Kolodziej, T.L., Karne, R.J., Crandon, S.K. & Quon, M.J. (2008). Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. American Journal of Clinical Nutrition, 88, 1685-1696.
64. Nejad, P.A. & Farsi, F. (2014). IRCT20130303264545N2 - Trial registration - Effect of dark chocolate on serum levels of liver enzymes, inflammation and oxidative stress status in patients with non alcoholic fatty liver disease.
65. de Oliveira, T.B., Rogero, M.M. & Genovese, M.I. (2015). Poliphenolic-rich extracts from cocoa (Theobroma cacao L.) and cupuassu (Theobroma grandiflorum Willd. Ex Spreng. K. Shum) liquors: a comparison of metabolic effects in high-fat fed rats. PharmaNutrition, 3, 20-28.
66. Orena, S., Owen, J., Jin, F., Fabian, M., Gillitt, N.D. & Zeisel, S.H. (2015). Extracts of fruits and vegetables activate the antioxidant response element in IMR-32 Cells. Journal of Nutrition, 145, 2006-2011.
67. Parsaeyan, N., Mozaffari-Khosravi, H., Absalan, A. & Mozayan, M.R. (2014). Beneficial effects of cocoa on lipid peroxidation and inflammatory markers in type 2 diabetic patients and investigation of probable interactions of cocoa active ingredients with prostaglandin synthase-2 (PTGS-2/COX-2) using virtual analysis. Journal of Diabetes and Metabolic Disorders, 13, 30.
68. Pascoe, J., Hollern, D., Stamateris, R. et al. (2012). Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes, 61, 632-641.
69. Petersen, K.F., Dufour, S., Savage, D.B. et al. (2007). The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 104, 12587-12594.
70. Rector, R.S., Thyfault, J.P., Wei, Y. & Ibdah, J.A. (2008). Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World Journal of Gastroenterology, 14, 185-192.
71. Roura, E., Andrés-Lacueva, C., Estruch, R. et al. (2007). Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Annals of Nutrition & Metabolism, 51, 493-498.
72. Ruzaidi, A.M.M., Jalil, A.M.M., Ismail, A., Nawalyah, A.G. & Muhaji, H. (2008). Protective effect of polyphenol-rich extract prepared from Malaysian cocoa (Theobroma cacao) on glucose levels and lipid profiles in streptozotocin-induced diabetic rats. Journal of the Science of Food and Agriculture, 88, 1442.
73. Ryan, M.C., Itsiopoulos, C., Thodis, T. et al. (2013). The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Journal of Hepatology, 59, 138-143.
74. Sarmadi, B., Aminuddin, F., Hamid, M., Saari, N., Abdul-Hamid, A. & Ismail, A. (2012). Hypoglycemic effects of cocoa (Theobroma cacao L.) autolysates. Food Chemistry, 134, 905-911.
75. Sarriá, B., Mateos, R., Sierra-Cinos, J.L., Goya, L., García-Diz, L. & Bravo, L. (2012). Hypotensive, hypoglycaemic and antioxidant effects of consuming a cocoa product in moderately hypercholesterolemic humans. Food and Function, 3, 867.
76. Sarriá, B., Martínez-López, S., Sierra-Cinos, J.L., García-Diz, L., Mateos, R. & Bravo, L. (2014). Regular consumption of a cocoa product improves the cardiometabolic profile in healthy and moderately hypercholesterolaemic adults. British Journal of Nutrition, 111, 122-134.
77. Sarriá, B., Martínez-López, S., Sierra-Cinos, J.L. et al. (2015). Effects of bioactive constituents in functional cocoa products on cardiovascular health in humans. Food Chemistry, 174, 214-218.
78. Schroeter, H., Holt, R.R., Orozco, T.J., Schmitz, H.H. & Keen, C.L. (2003). Nutrition: milk and absorption of dietary flavanols. Nature, 426, 787-788.
79. Schugar, R.C. & Crawford, P.A. (2012). Low-carbohydrate ketogenic diets, glucose homeostasis, and non alcoholic fatty liver disease Current Opinion in Clinical Nutrition & Metabolic Care, 15, 374-380.
80. Si, H., Fu, Z., Velayutham, P. et al. (2011). Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster. Journal of Nutrition, 141, 1095-1100.
81. Sluijs, I., Cadier, E., Beulens, J.W.J., van der A, D.L., Spijkerman, A.M.W. & van der Schouw, Y.T. (2015). Dietary intake of carotenoids and risk of type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases, 25, 376-381.
82. Sugiura, M., Nakamura, M., Ogawa, K., Ikoma, Y. & Yano, M. (2012). High serum carotenoids associated with lower risk for bone loss and osteoporosis in post-menopausal Japanese female subjects: prospective cohort study. PLoS ONE, 7, e52643.
83. Taylor, R. (2013). Banting Memorial Lecture 2012 Reversing the twin cycles of type 2 diabetes. Diabetic Medicine, 30, 267-275.
84. Threapleton, D.E., Burley, V.J., Greenwood, D.C. & Cade, J.E. (2015). Dietary fibre intake and risk of ischaemic and haemorrhagic stroke in the UK Women's Cohort Study. European Journal of Clinical Nutrition, 69, 467-474.
85. Tomaru, M., Takano, H., Osakabe, N. et al. (2007). Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice. Nutrition, 23, 351-355.
86. Turner, R.C., Cull, C.A., Frighi, V. & Holman, R.R. (2005). Metformin, or insulin in patients. American Medical Association, 281, 2005-2012.
87. Vernon, G., Baranova, A. & Younossi, Z.M. (2011). Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics, 34, 274-285.
88. Wasiu, O.E., Omobola, O.A., Adebayo, A.A., Onakomaya, A. & Olawale, O.O. (2014). Modification of cardiovascular disease risk predictor (atherogenic and coronary risk indices) in type 2 diabetes mellitus by aqueous cocoa powder extract. Der Pharmacie Lettre, 6, 261-266.
89. West, S.G., McIntyre, M.D., Piotrowski, M.J. et al. (2014). Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults. British Journal of Nutrition, 111, 653-661.
90. Williams, R.J., Spencer, J.P.E. & Rice-Evans, C. (2004). Flavonoids: antioxidants or signalling molecules?. Free Radical Biology and Medicine, 36, 838-849.
91. Yamashita, Y., Okabe, M., Natsume, M. & Ashida, H. (2012). Prevention mechanisms of glucose intolerance and obesity by cacao liquor procyanidin extract in high-fat diet-fed C57BL/6 mice. Archives of Biochemistry and Biophysics, 527, 95-104.
92. Yilmaz, B., Sahin, K., Bilen, H. et al. (2015). Carotenoids and non-alcoholic fatty liver. Hepatobiliary Surgery and Nutrition, 4, 161-171.